Bank of New York Mellon’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.7M | Buy |
|
|||||
|
2025
Q1 | $2.64M | Buy |
|
|||||
|
2024
Q4 | $3.01M | Buy |
|
|||||
|
2024
Q3 | $3.52M | Sell |
|
|||||
|
2024
Q2 | $4.25M | Buy |
|
|||||
|
2024
Q1 | $5.13M | Sell |
|
|||||
|
2023
Q4 | $6.75M | Buy |
|
|||||
|
2023
Q3 | $4.78M | Sell |
|
|||||
|
2023
Q2 | $6.07M | Sell |
|
|||||
|
2023
Q1 | $4.92M | Sell |
|
|||||
|
2022
Q4 | $4.43M | Sell |
|
|||||
|
2022
Q3 | $7.74M | Buy |
|
|||||
|
2022
Q2 | $6.18M | Buy |
|
|||||
|
2022
Q1 | $5.72M | Buy |
|
|||||
|
2021
Q4 | $4.9M | Buy |
|
|||||
|
2021
Q3 | $6.95M | Buy |
|
|||||
|
2021
Q2 | $9.93M | Buy |
|
|||||
|
2021
Q1 | $5.47M | Buy |
|
|||||
|
2020
Q4 | $6.1M | Sell |
|
|||||
|
2020
Q3 | $20.1M | Buy |
|
|||||
|
2020
Q2 | $16.4M | Buy |
|
|||||
|
2020
Q1 | $8.88M | Buy |
|
|||||
|
2019
Q4 | $2.81M | Buy |
|
|||||
|
2019
Q3 | $1.61M | Buy |
|
|||||
|
2019
Q2 | $1.56M | Buy |
|
|||||
|
2019
Q1 | $546K | Sell |
|
|||||
|
2018
Q4 | $493K | Sell |
|
|||||
|
2018
Q3 | $1.53M | Buy |
|
|||||
|
2018
Q2 | $1.83M | Buy |
|
|||||
|
2018
Q1 | $995K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $288K | Buy |
|